Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution
 Back to Profile

Elizabeth Blair

Concepts (341)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Squamous Cell
19
2019
1043
1.690
 Why?
Head and Neck Neoplasms
24
2017
1013
1.630
 Why?
Salivary Gland Neoplasms
5
2019
62
1.460
 Why?
Carcinoma, Mucoepidermoid
2
2019
17
1.440
 Why?
Chemoradiotherapy
14
2022
295
1.120
 Why?
Neoplasm Recurrence, Local
12
2019
1204
0.980
 Why?
Oropharyngeal Neoplasms
6
2022
120
0.900
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2022
2356
0.890
 Why?
Mouth Neoplasms
7
2018
181
0.780
 Why?
Paranasal Sinus Diseases
2
2018
23
0.780
 Why?
Gene Rearrangement
2
2019
171
0.760
 Why?
Papillomavirus Infections
5
2022
225
0.740
 Why?
Neoplasm Grading
1
2019
333
0.690
 Why?
Laryngeal Diseases
2
2015
17
0.680
 Why?
Nose Diseases
1
2017
10
0.680
 Why?
Nose Neoplasms
1
2017
31
0.680
 Why?
Maxillary Sinus
2
2018
26
0.650
 Why?
Nasal Cavity
1
2017
101
0.640
 Why?
Trans-Activators
1
2019
449
0.610
 Why?
Paranasal Sinus Neoplasms
1
2016
24
0.600
 Why?
Aspergillosis
1
2016
46
0.590
 Why?
Cementoma
1
2015
2
0.590
 Why?
Mandibular Neoplasms
1
2015
25
0.570
 Why?
Sarcoidosis
1
2015
91
0.540
 Why?
Papillomaviridae
4
2022
147
0.540
 Why?
Laryngeal Neoplasms
5
2017
87
0.530
 Why?
Sjogren's Syndrome
3
2009
29
0.500
 Why?
Salivary Glands, Minor
2
2009
10
0.490
 Why?
Middle Aged
43
2022
25918
0.460
 Why?
Aged, 80 and over
21
2020
6680
0.450
 Why?
Otolaryngology
1
2012
40
0.440
 Why?
Airway Management
1
2012
38
0.440
 Why?
Female
51
2022
45495
0.420
 Why?
Humans
68
2022
85326
0.410
 Why?
Adult
39
2022
26372
0.400
 Why?
Placenta
1
2011
205
0.390
 Why?
Anesthesiology
1
2012
164
0.380
 Why?
Aged
34
2020
18815
0.380
 Why?
Quinazolines
4
2012
220
0.380
 Why?
Induction Chemotherapy
6
2022
143
0.370
 Why?
Male
48
2022
42565
0.360
 Why?
Disease-Free Survival
15
2020
1209
0.350
 Why?
Neck
2
2020
98
0.330
 Why?
Head
2
2020
126
0.320
 Why?
Hydroxyurea
9
2012
231
0.320
 Why?
Radiotherapy, Intensity-Modulated
5
2016
182
0.310
 Why?
Clinical Competence
1
2012
726
0.300
 Why?
Radiotherapy Dosage
11
2020
485
0.290
 Why?
Warts
2
2019
11
0.290
 Why?
Fluorouracil
9
2012
567
0.280
 Why?
Tongue Neoplasms
4
2018
52
0.280
 Why?
Nasopharyngeal Neoplasms
2
2016
44
0.280
 Why?
Diagnosis, Differential
4
2017
1612
0.270
 Why?
Alphapapillomavirus
2
2021
43
0.250
 Why?
Treatment Outcome
17
2022
8047
0.250
 Why?
Antineoplastic Agents
6
2012
2379
0.250
 Why?
Neoplasm Staging
12
2016
1953
0.230
 Why?
Paclitaxel
5
2022
464
0.230
 Why?
Laryngostenosis
1
2021
14
0.220
 Why?
Tracheal Stenosis
1
2021
23
0.220
 Why?
Carcinoma
2
2016
444
0.220
 Why?
Drug Monitoring
1
2022
121
0.210
 Why?
Carcinoma, Papillary, Follicular
1
2020
11
0.210
 Why?
DNA, Viral
1
2022
281
0.210
 Why?
Respiratory System
1
2021
115
0.210
 Why?
In Situ Hybridization, Fluorescence
2
2019
362
0.200
 Why?
ras Proteins
1
2020
133
0.200
 Why?
Smoking
3
2014
572
0.200
 Why?
Follow-Up Studies
13
2019
3896
0.190
 Why?
Proto-Oncogene Proteins B-raf
1
2020
137
0.190
 Why?
Lymph Nodes
2
2016
540
0.190
 Why?
Thyroid Neoplasms
2
2020
442
0.190
 Why?
Risk Factors
8
2019
5511
0.190
 Why?
Arteries
1
2020
192
0.190
 Why?
Heterocyclic Compounds
1
2019
16
0.190
 Why?
Retrospective Studies
15
2018
7983
0.190
 Why?
Practice Guidelines as Topic
2
2017
1096
0.190
 Why?
Immunologic Deficiency Syndromes
1
2019
45
0.190
 Why?
Radiation Dosage
1
2020
232
0.190
 Why?
Young Adult
6
2022
6100
0.180
 Why?
Bone Cysts, Aneurysmal
1
2018
7
0.180
 Why?
Receptors, CXCR4
1
2019
41
0.180
 Why?
Lip
2
2009
16
0.180
 Why?
Prognosis
9
2022
3751
0.180
 Why?
Combined Modality Therapy
9
2016
1693
0.180
 Why?
Orthodontic Appliances
1
2018
8
0.180
 Why?
Dental Alloys
1
2018
7
0.180
 Why?
Precancerous Conditions
2
2016
208
0.180
 Why?
Deglutition
3
2020
70
0.180
 Why?
Ubiquitin Thiolesterase
1
2018
57
0.180
 Why?
Inflammation
2
2017
865
0.170
 Why?
Glottis
1
2017
12
0.170
 Why?
Child
6
2019
6954
0.170
 Why?
Bone Marrow
1
2019
425
0.160
 Why?
Adolescent
7
2022
9323
0.160
 Why?
Hypopharyngeal Neoplasms
2
2011
15
0.160
 Why?
Life Style
1
2018
194
0.160
 Why?
Fibrosis
1
2017
200
0.160
 Why?
Prospective Studies
7
2022
4179
0.150
 Why?
Transcriptome
1
2020
541
0.150
 Why?
Fibroma, Ossifying
1
2015
5
0.150
 Why?
Neoplasm Invasiveness
3
2016
537
0.150
 Why?
Anticarcinogenic Agents
1
2016
73
0.150
 Why?
Time Factors
4
2019
5561
0.140
 Why?
Guideline Adherence
1
2017
231
0.140
 Why?
Premedication
1
1995
58
0.140
 Why?
Pleural Neoplasms
1
2017
183
0.140
 Why?
Gene Expression Regulation, Neoplastic
1
2020
1212
0.140
 Why?
Cerebellopontine Angle
1
1994
7
0.140
 Why?
Ulnar Nerve
1
1994
6
0.140
 Why?
Neuroma, Acoustic
1
1994
16
0.130
 Why?
Tumor Virus Infections
1
2014
82
0.130
 Why?
Predictive Value of Tests
1
2019
1783
0.130
 Why?
Maximum Tolerated Dose
3
2012
272
0.130
 Why?
Neuromuscular Blocking Agents
1
1994
35
0.130
 Why?
Leukoplakia, Oral
1
2013
9
0.130
 Why?
Facial Nerve
1
1994
35
0.130
 Why?
Aminolevulinic Acid
1
2013
22
0.130
 Why?
Photosensitizing Agents
1
2013
47
0.130
 Why?
Anti-Bacterial Agents
2
1999
834
0.120
 Why?
Carboplatin
3
2022
274
0.120
 Why?
Biopsy
4
2009
1196
0.120
 Why?
Monitoring, Intraoperative
1
1994
147
0.120
 Why?
Mouth
2
2011
54
0.120
 Why?
Photochemotherapy
1
2013
99
0.120
 Why?
Pain
1
2015
375
0.120
 Why?
Radiation-Sensitizing Agents
1
2012
102
0.120
 Why?
Education, Medical, Graduate
1
2016
352
0.110
 Why?
Deglutition Disorders
2
2011
90
0.110
 Why?
Radiotherapy
2
2011
342
0.110
 Why?
Lymph Node Excision
1
2013
212
0.110
 Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.110
 Why?
Chemotherapy, Adjuvant
5
2012
472
0.110
 Why?
Research Design
2
2013
584
0.110
 Why?
Survival Analysis
5
2018
1601
0.110
 Why?
Organ Preservation
1
2011
75
0.110
 Why?
Tracheotomy
1
2011
20
0.110
 Why?
Protein Kinase Inhibitors
1
2016
574
0.110
 Why?
Survival Rate
4
2019
1938
0.100
 Why?
Speech
1
2010
72
0.100
 Why?
Brain Diseases
1
2011
190
0.100
 Why?
Vocal Cords
1
2009
19
0.100
 Why?
Genetic Predisposition to Disease
1
2019
2251
0.100
 Why?
Agammaglobulinemia
1
2010
21
0.100
 Why?
Airway Obstruction
1
2011
118
0.100
 Why?
Developmental Disabilities
1
2011
193
0.100
 Why?
Quality of Life
3
2012
1413
0.100
 Why?
Emergency Medical Services
1
2012
188
0.100
 Why?
Vascular Endothelial Growth Factor A
2
2009
390
0.090
 Why?
Kaplan-Meier Estimate
4
2013
907
0.090
 Why?
Radiotherapy, High-Energy
1
2008
50
0.090
 Why?
Cohort Studies
5
2018
2764
0.090
 Why?
Confidence Intervals
4
2018
236
0.090
 Why?
Enteral Nutrition
2
2020
108
0.090
 Why?
Neck Dissection
4
2010
72
0.090
 Why?
Myelitis, Transverse
1
2008
10
0.090
 Why?
Submandibular Gland Diseases
1
2008
9
0.090
 Why?
Military Personnel
1
2009
78
0.090
 Why?
Neoplasms, Second Primary
1
2011
251
0.090
 Why?
Genomics
1
2014
666
0.090
 Why?
United States
6
2018
6541
0.090
 Why?
Neuromyelitis Optica
1
2008
18
0.090
 Why?
Neoadjuvant Therapy
2
2012
286
0.090
 Why?
Skin
1
2012
560
0.090
 Why?
Aortic Aneurysm
1
1988
81
0.090
 Why?
Fatal Outcome
2
2019
309
0.080
 Why?
Taxoids
1
2007
132
0.080
 Why?
Risk Assessment
5
2016
2305
0.080
 Why?
Sinus Thrombosis, Intracranial
1
2006
11
0.080
 Why?
DNA
1
2012
1306
0.080
 Why?
Tinnitus
1
2006
20
0.080
 Why?
Headache
1
2006
71
0.080
 Why?
Incidence
3
2018
1667
0.070
 Why?
Prodrugs
2
1996
48
0.070
 Why?
Drug Administration Schedule
4
2016
973
0.070
 Why?
Dose-Response Relationship, Drug
3
2019
2104
0.070
 Why?
Infant, Newborn
1
2011
2478
0.070
 Why?
Antibodies, Monoclonal
2
2010
1534
0.070
 Why?
Drug Therapy, Combination
3
1999
1001
0.070
 Why?
Cisplatin
2
2022
585
0.070
 Why?
Gastroesophageal Reflux
2
2009
127
0.070
 Why?
Pregnancy
1
2011
2911
0.070
 Why?
Adenocarcinoma
1
2011
1205
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2017
102
0.060
 Why?
Radiotherapy, Adjuvant
3
2010
311
0.060
 Why?
Internship and Residency
1
2012
933
0.060
 Why?
Tomography, X-Ray Computed
2
2011
2601
0.060
 Why?
Remission Induction
2
2016
717
0.060
 Why?
Retreatment
2
2012
107
0.060
 Why?
Pulmonary Surgical Procedures
1
2021
8
0.060
 Why?
Immunohistochemistry
3
2017
1836
0.060
 Why?
Alcohol Drinking
2
2018
276
0.060
 Why?
Receptor, Endothelin A
1
2021
24
0.060
 Why?
Gene Expression Profiling
2
2020
1393
0.060
 Why?
Clinical Trials, Phase II as Topic
2
2013
174
0.060
 Why?
Endothelial Growth Factors
1
2001
60
0.050
 Why?
Respiratory Function Tests
1
2021
148
0.050
 Why?
Lymphokines
1
2001
115
0.050
 Why?
Constriction, Pathologic
1
2021
216
0.050
 Why?
Periodontal Diseases
1
2000
10
0.050
 Why?
Radiography
2
2014
882
0.050
 Why?
Bronchoscopy
1
2021
151
0.050
 Why?
Lymphoid Tissue
1
2000
63
0.050
 Why?
Hyperplasia
1
2000
159
0.050
 Why?
Clindamycin
2
1999
16
0.050
 Why?
Disease Progression
2
2017
1488
0.050
 Why?
Antibodies, Monoclonal, Humanized
3
2011
965
0.050
 Why?
Cefuroxime
2
1996
3
0.050
 Why?
Tonsillectomy
1
1999
28
0.050
 Why?
Carcinoma, Papillary
1
2001
182
0.050
 Why?
Feasibility Studies
1
2022
770
0.050
 Why?
Benzylamines
1
2019
16
0.050
 Why?
Neoplasms, Squamous Cell
1
2019
19
0.050
 Why?
Patient-Centered Care
1
2021
191
0.050
 Why?
Aortic Rupture
2
1990
53
0.050
 Why?
Bone Marrow Examination
1
2019
53
0.050
 Why?
Patient Care Team
1
2021
280
0.050
 Why?
Antibiotic Prophylaxis
1
1999
83
0.050
 Why?
Primary Myelofibrosis
1
2019
53
0.050
 Why?
Evidence-Based Medicine
1
2021
458
0.040
 Why?
Oral Health
1
2018
10
0.040
 Why?
Double-Blind Method
3
2016
1916
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
11
0.040
 Why?
Myoepithelioma
1
2017
11
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2017
24
0.040
 Why?
Metals
1
2018
93
0.040
 Why?
Laryngectomy
1
2017
26
0.040
 Why?
Surgical Wound Infection
2
1999
190
0.040
 Why?
Parotid Gland
1
2017
35
0.040
 Why?
Multivariate Analysis
2
2011
1026
0.040
 Why?
Statistics, Nonparametric
2
2009
326
0.040
 Why?
Adenocarcinoma, Clear Cell
1
2017
59
0.040
 Why?
Oncogene Proteins, Fusion
1
2017
124
0.040
 Why?
Probability
2
2008
362
0.040
 Why?
Otitis Media
1
1996
15
0.040
 Why?
Translocation, Genetic
1
2017
263
0.040
 Why?
Mutation
2
2020
3900
0.040
 Why?
Loss of Heterozygosity
1
2016
88
0.040
 Why?
Otitis Media with Effusion
1
1995
7
0.040
 Why?
Pyrazoles
1
2017
169
0.040
 Why?
Analgesics, Opioid
1
2020
386
0.040
 Why?
Cutaneous Fistula
1
1995
13
0.040
 Why?
Cellulitis
1
1995
22
0.040
 Why?
Cephalosporins
1
1995
43
0.040
 Why?
Dissection
1
1995
48
0.040
 Why?
Pyridines
1
2017
313
0.040
 Why?
Human papillomavirus 18
1
2014
16
0.030
 Why?
Magnetic Resonance Imaging
3
2017
3318
0.030
 Why?
Costs and Cost Analysis
1
1995
154
0.030
 Why?
Human papillomavirus 16
1
2014
38
0.030
 Why?
Protein Interaction Maps
1
2014
50
0.030
 Why?
Drug Costs
1
1995
63
0.030
 Why?
Sex Factors
1
2018
1098
0.030
 Why?
Hospital Costs
1
1995
104
0.030
 Why?
Administration, Oral
1
2016
730
0.030
 Why?
Electromyography
1
1994
182
0.030
 Why?
Amoxicillin-Potassium Clavulanate Combination
3
1999
4
0.030
 Why?
Clavulanic Acids
3
1999
4
0.030
 Why?
Drug Resistance, Neoplasm
1
2017
581
0.030
 Why?
Societies, Medical
1
2017
580
0.030
 Why?
Amoxicillin
3
1999
14
0.030
 Why?
DNA Copy Number Variations
1
2014
182
0.030
 Why?
Multicenter Studies as Topic
1
2013
156
0.030
 Why?
Electric Stimulation
1
1994
378
0.030
 Why?
Rabbits
1
1994
733
0.030
 Why?
Age Factors
1
2018
1933
0.030
 Why?
Platinum
1
2012
58
0.030
 Why?
Aorta, Abdominal
2
1990
62
0.030
 Why?
Phenotype
1
2019
2334
0.030
 Why?
Organ Sparing Treatments
1
2011
39
0.030
 Why?
Supraglottitis
1
2011
3
0.030
 Why?
Length of Stay
1
1995
718
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2012
192
0.030
 Why?
Glutamates
1
2011
94
0.030
 Why?
Leucovorin
1
2010
220
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2011
150
0.030
 Why?
Antimetabolites, Antineoplastic
1
2012
251
0.030
 Why?
Osteoradionecrosis
1
2010
15
0.030
 Why?
Guanine
1
2011
208
0.030
 Why?
Antineoplastic Agents, Phytogenic
1
2012
298
0.020
 Why?
Interferon-alpha
1
2010
241
0.020
 Why?
Postoperative Period
1
2010
314
0.020
 Why?
Laryngoscopy
1
2009
39
0.020
 Why?
Camptothecin
1
2010
196
0.020
 Why?
Siblings
1
2010
113
0.020
 Why?
Deoxycytidine
1
2011
242
0.020
 Why?
Treatment Failure
1
2010
307
0.020
 Why?
Dose-Response Relationship, Radiation
1
2009
201
0.020
 Why?
Transforming Growth Factor alpha
1
2009
52
0.020
 Why?
Syndrome
1
2010
437
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
80
0.020
 Why?
Postoperative Complications
1
1999
2316
0.020
 Why?
Chi-Square Distribution
1
2009
385
0.020
 Why?
Bone Marrow Cells
1
2010
261
0.020
 Why?
Arteriosclerosis
1
1988
166
0.020
 Why?
Hypersensitivity
1
2009
144
0.020
 Why?
Recombinant Proteins
1
2010
1068
0.020
 Why?
Bacterial Infections
1
2010
228
0.020
 Why?
Neoplasm Metastasis
1
2012
1063
0.020
 Why?
Lymphatic Metastasis
1
2009
508
0.020
 Why?
Regression Analysis
1
2009
631
0.020
 Why?
Autoantibodies
1
2008
263
0.020
 Why?
Cranial Sinuses
1
2006
13
0.020
 Why?
Odds Ratio
1
2008
694
0.020
 Why?
Blood Vessel Prosthesis
1
1988
231
0.020
 Why?
Neoplasm Proteins
1
2010
551
0.020
 Why?
Comorbidity
1
2009
954
0.020
 Why?
Endothelium, Vascular
1
1988
450
0.020
 Why?
Cerebrovascular Circulation
1
2006
224
0.020
 Why?
Prevalence
1
2008
1288
0.020
 Why?
Coronary Artery Disease
1
1988
376
0.020
 Why?
Preoperative Care
1
2006
418
0.020
 Why?
Signal Transduction
1
2014
3337
0.020
 Why?
Algorithms
1
2011
1858
0.010
 Why?
Registries
1
2006
688
0.010
 Why?
Asthma
1
2009
909
0.010
 Why?
Vascular Endothelial Growth Factors
1
2001
62
0.010
 Why?
Case-Control Studies
1
2006
1839
0.010
 Why?
Ticarcillin
1
1999
2
0.010
 Why?
Mouthwashes
1
1999
5
0.010
 Why?
Ampicillin
1
1999
29
0.010
 Why?
Administration, Topical
1
1999
98
0.010
 Why?
Injections, Intravenous
1
1999
270
0.010
 Why?
Infant
2
1996
3163
0.010
 Why?
Child, Preschool
2
1996
3820
0.010
 Why?
Pilot Projects
1
1999
844
0.010
 Why?
Suspensions
1
1996
8
0.010
 Why?
Animals
2
1994
27411
0.010
 Why?
Bacteria
1
1999
469
0.010
 Why?
Acute Disease
1
1996
877
0.010
 Why?
Back Pain
1
1990
37
0.010
 Why?
Hematoma
1
1990
97
0.010
 Why?
6-Ketoprostaglandin F1 alpha
1
1988
6
0.010
 Why?
Polytetrafluoroethylene
1
1988
70
0.010
 Why?
Microscopy, Electron, Scanning
1
1988
160
0.010
 Why?
Jugular Veins
1
1988
76
0.010
 Why?
Omentum
1
1988
70
0.010
 Why?
Microcirculation
1
1988
114
0.010
 Why?
Dogs
1
1988
811
0.010
 Why?
Aorta
1
1988
299
0.000
 Why?
Thrombosis
1
1988
279
0.000
 Why?
Blair's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (341) concept(s)
_
Co-Authors Expand Description
See all (45) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_